U.S. Markets close in 2 hrs 19 mins

Verastem, Inc. (VSTM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.37+0.03 (+0.56%)
As of 1:41PM EDT. Market open.
People also watch
Full screen
Previous Close5.34
Bid5.34 x 900
Ask5.36 x 1700
Day's Range5.28 - 5.44
52 Week Range1.05 - 5.71
Avg. Volume1,583,887
Market Cap198.65M
PE Ratio (TTM)-4.32
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com13 days ago

    Verastem Shares Are Exploding 50% -- Here's Why

    The Boston firm unveils positive results from its Phase 3 study of duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

  • Reuters13 days ago

    Verastem's blood cancer drug succeeds in late-stage trial

    Verastem Inc said on Wednesday its drug to treat some types of blood cancer met the main goal of a late-stage study, sending the U.S. drug developer's shares up as much as 44.5 percent. Verastem said its drug, duvelisib, reduced the risk of disease progression or death in patients by 48 percent when compared with the current standard of care, Novartis's Arzerra. The oral drug was tested in 319 patients suffering from chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who did not respond to initial treatment or whose cancer had relapsed.

  • Implied Volatility Surging for Verastem (VSTM) Stock Options
    Zackslast month

    Implied Volatility Surging for Verastem (VSTM) Stock Options

    Verastem (VSTM) needs Investors to pay close attention to the stock based on moves in the options market lately.